News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
NVIDIA's Rival Cerebras Plans to Raise IPO Price Range, Sees 20x Oversubscription: Wire
NVIDIA Corporation (NVDA.US) rival and AI chipmaker Cerebras Systems has posted strong demand for its IPO, Reuters reported, citing people with the knowledge of the matter. The com...
Reset
Send
The window will close in 5 seconds
NVIDIA's Rival Cerebras Plans to Raise IPO Price Range, Sees 20x Oversubscription: Wire
Close
Recommend
6
Positive
8
Negative
0
 
 

NVIDIA Corporation (NVDA.US)      rival and AI chipmaker Cerebras Systems has posted strong demand for its IPO, Reuters reported, citing people with the knowledge of the matter.

The company plans to raise its IPO price range from USD115-125 per share to USD150-160, while scaling up the offering from 28 million shares to 30 million shares.

Related NewsNon Farm Payrolls for Apr in the United States is 115K, lower than the previous value of 185K. The forecast was 62K.
At the top end price of USD160 per share, Cerebras will raise approximately USD4.8 billion, higher than the originally planned USD3.5 billion. The IPO has so far recorded about 20x oversubscription, report said.
(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.